Clinical Trial: Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: A Pilot Study of Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Brief Summary: The purpose of the study is to evaluate the safety and effectiveness of siltuximab for participants being treated for large granular lymphocytic leukemia (LGLL).